Hiroaki Suzuki
- Molecular Biology top 5%
- Surgery top 5%
- Epidemiology top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Physiology top 5%
- Co-authors
- Hitoshi ShimanoNobuhiro YamadaHirohito SoneAkimitsu TakahashiNaoya YahagiYoshimi NakagawaTakashi MatsuzakaHideo Toyoshima
- Topics
- Cholesterol and Lipid Metabolism (16 papers)Peroxisome Proliferator-Activated Receptors (14 papers)Pancreatic function and diabetes (10 papers)
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Hiroaki Suzuki
117 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.6k
- Surgery 911
- Epidemiology 603
- Endocrinology, Diabetes and Metabolism 544
- Physiology 538
Countries citing papers authored by Hiroaki Suzuki
This map shows the geographic impact of Hiroaki Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Suzuki more than expected).
Fields of papers citing papers by Hiroaki Suzuki
This network shows the impact of papers produced by Hiroaki Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Suzuki. The network helps show where Hiroaki Suzuki may publish in the future.
Co-authorship network of co-authors of Hiroaki Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Suzuki. A scholar is included among the top collaborators of Hiroaki Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Suzuki. Hiroaki Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 21 | |
| 6 | 10 | |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 43 | |
| 11 | 2 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | 57 | |
| 15 | 17 | |
| 16 | 61 | |
| 17 | 127 | |
| 18 | 3 | |
| 19 | Relationship Between Fractional Myocardial Flow Reserve and Myocardial Residual Viability in Recent Myocardial Infarction | 1 |
| 20 | 17 |
About Hiroaki Suzuki
Hiroaki Suzuki is a scholar working on Biochemistry, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 122 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (16 papers), Peroxisome Proliferator-Activated Receptors (14 papers) and Pancreatic function and diabetes (10 papers). The work is most often cited by research in Biochemistry (281 citations), Cancer Research (495 citations) and Endocrinology, Diabetes and Metabolism (544 citations). Hiroaki Suzuki has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Hitoshi Shimano, Nobuhiro Yamada, Hirohito Sone, Akimitsu Takahashi, Naoya Yahagi, Yoshimi Nakagawa, Takashi Matsuzaka, Hideo Toyoshima, Takashi Yamamoto and Shigeru Yatoh. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.